Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-005618

Options or other derivatives

  • Chief Operating Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hexter Joshua Chief Operating Officer 2018-05-03 Grant or award · Stock option (right to buy) +30,000 30,000 D
Loading xslF345X03/f4050318hexter_oramedpharm.xml…